Johnson & Johnson Initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate
The FINANCIAL -- The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the ...
ADVERTISEMENT
